Bupivacaine and Dexmedetomidine

Phase 3Small molecule

Bupivacaine and Dexmedetomidine is one of 15 small molecule programs targeting Laparoscopic Cholecystectomy. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Laparoscopic CholecystectomyNot yet recruiting

Laparoscopic CholecystectomyPhase 3

Not yet recruiting

Competition

Competitive Landscape

20 competitors in Laparoscopic Cholecystectomy

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

11 2

Duragesic

CCephalon

Approved

6 3

Nubain

AAultman Health Foundation

Approved

2 4

Kytril

CConrado Roberto Hoffmann Filho

Approved

2 5

Bupivacaine and Dexmedetomidine

KKafrelsheikh University

Phase 3

1 6

Bupivacaine and Fentanyl

WWeill Medical College of Cornell University

Phase 3

1 7

Epsom Salt

FFresenius Kabi USA, LLC

Preclinical

6 8

Spravato

WWim Janssens

Preclinical

1 9

Normodyne

AAlvogen Korea

Preclinical

1 10

Tab. Midazolam

BBenazir Bhutto Hospital, Rawalpindi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Supraclavicular Brachial Plexus Block1 trial

Efficacy and Safety of Dexmedetomidine to Bupivacaine in Supraclavicular Brachial Plexus Block

Completed·KKafrelsheikh University·N/A·NCT06020781·75 enrolled

Laparoscopic Cholecystectomy1 trial

Comparison Between Dexmedetomidine and Fentanyl As an Adjuvant to Bupivacaine in the Paravertebral Nerve Block in Laparoscopic Cholecystectomy for Postoperative Analgesia: Randomized Comparative Clinical Trial.

Not yet recruiting·—·Phase 4·NCT06752629·50 enrolled

Unspecified1 trial

Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery ;Arandomized Non - Inferiority Study

Completed·BBenha University·Phase 2·NCT07465185·300 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Bupivacaine and Dexmedetomidine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bupivacaine and Dexmedetomidine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bupivacaine and Dexmedetomidine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Kafrelsheikh University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: KKafrelsheikh University

Bupivacaine and Dexmedetomidine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Supraclavicular Brachial Plexus Block1 trial

Laparoscopic Cholecystectomy1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News